about
Clinical lung xenotransplantation--what donor genetic modifications may be necessary?Immunobiological barriers to xenotransplantationGenetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organsBioprosthetic heart valves of the futureImpact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance.Hepatic function after genetically engineered pig liver transplantation in baboons.Clinical pig liver xenotransplantation: how far do we have to go?Thrombocytopenia after pig-to-baboon liver xenotransplantation: where do platelets go?Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation.Immunobiology of liver xenotransplantation.Pig-to-baboon heterotopic heart transplantation--exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens.Current status of pig liver xenotransplantation.Further evidence for sustained systemic inflammation in xenograft recipients (SIXR).Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.Are there advantages in the use of specific pathogen-free baboons in pig organ xenotransplantation models?Overcoming the barriers to xenotransplantation: prospects for the futureEx vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigsHistopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionThe role of genetically engineered pigs in xenotransplantation research.Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literatureClinical islet xenotransplantation: how close are we?Glucose metabolism in pigs expressing human genes under an insulin promoter.Systemic inflammation in xenograft recipients precedes activation of coagulationKidney transplantation from donors with hepatitis C infection.Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsA brief history of clinical xenotransplantation.The need for xenotransplantation as a source of organs and cells for clinical transplantation.Comparison of hematologic, biochemical, and coagulation parameters in α1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate speciesExpression of NeuGc on Pig Corneas and Its Potential Significance in Pig Corneal Xenotransplantation.Thyroid hormone: relevance to xenotransplantation.Update: cardiac xenotransplantation.Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood?Technique of endoscopic biopsy of islet allografts transplanted into the gastric submucosal space in pigsPig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates.Porcine alanine transaminase after liver allo-and xenotransplantationPorcine bioprosthetic heart valves: The next generation.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.A Novel Approach in Combined Liver and Kidney Transplantation With Long-term Outcomes.Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition.
P50
Q26823663-0E510AE6-19D9-458A-A12F-C7D9F1951C42Q28081993-0C2B22F2-624F-4845-A3B9-8A2001B46B32Q28732872-5CD24413-765D-4BDF-8F54-0BC0CF9843D0Q28829371-ED598305-8040-454F-8112-47A988399F68Q33387654-F5090D5E-4E27-41C9-A415-FED051DFD58DQ33390545-0257820E-5476-4C85-B3C7-DDC8C16531FAQ33395889-C64D6C12-C3EE-4DFA-9AFD-7F26E32EC3E4Q33398735-F0593E1D-DA07-408B-A3E2-B167F385C20EQ33401474-72F2B5F9-9CD7-47BE-9618-D12B47D4F3D0Q33403888-A15BF9B2-95A2-4DDF-838D-1FD46885BF68Q33421736-6136BF92-D955-412C-93EA-5567DDFEB860Q33424602-1DAFEDEC-01C3-43F9-8D08-8E50B14735CBQ33425296-33334A9F-8446-427E-B65F-D29B517AD8FCQ33433973-69712A83-D5B2-4FB8-8DA1-DC2ADFFA1067Q33717670-AF3794BC-E9EB-4330-BCA8-488E9F264E3DQ33801035-8C8950AF-E489-4F45-8DE7-E95D999142B1Q33918452-DC13223B-F161-4CBA-B79D-09516071C34EQ34018912-586211BA-6A36-428C-A66C-CB731D44FA7CQ34044894-2AC201DC-4CEB-464F-8C38-9C0EE404E233Q34250530-D8D25B10-5395-4319-AD4D-B8AC9F5E9AD5Q34313171-99BA75DC-9583-4630-8581-54E3EEE85C89Q35085119-CFADA615-D34E-4540-BA13-9E28ACF45D3EQ35085219-8E07E38F-A0F2-48A6-B2A6-160AFCB4667EQ35128555-4D5A646B-55E6-4174-83ED-18550D93F959Q35202459-0BD0C08A-0DFB-41DF-B362-F7B09EB4E8FFQ36386211-41A7FFF7-690D-436C-9D4E-36339747433FQ36386220-714AE9D5-3B16-4744-967D-71150D36E929Q36442981-75EC01C4-26D2-4C38-A531-CD0499C09E99Q36843013-3B812111-38C5-488F-969E-1885B3DC67A5Q37184231-3DB22FC8-855D-4F9B-B418-99195B733980Q37342534-655E8757-499F-444E-B999-C5B73D1A630CQ37401609-763486EB-2A1D-414E-BFB7-396DA93E6FCBQ37407602-F39F3718-118A-439E-AF0D-79DB8FE3218AQ37424698-B872431B-87D1-48C1-97C3-3CA509D64F36Q37854406-006237FD-2AD4-4D3C-85CB-5B7B682A3764Q37987618-EED0B113-BCB8-4D67-8F15-BAB0166C8C55Q38033335-A2CF0431-DCFC-4941-9AE1-1BF5CCE0EA47Q38191251-DE1C30B9-0D34-4A81-A20D-29658E4C6BA7Q38842389-4AD220A4-4A96-44CB-8C93-54402AA90AC7Q39246204-E4FBF272-E922-44AF-ABD4-FB34F4660DF0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Burcin Ekser
@ast
Burcin Ekser
@en
Burcin Ekser
@es
Burcin Ekser
@nl
Burcin Ekser
@sl
type
label
Burcin Ekser
@ast
Burcin Ekser
@en
Burcin Ekser
@es
Burcin Ekser
@nl
Burcin Ekser
@sl
prefLabel
Burcin Ekser
@ast
Burcin Ekser
@en
Burcin Ekser
@es
Burcin Ekser
@nl
Burcin Ekser
@sl
P106
P1153
13605998500
P31
P496
0000-0003-0741-8007